Who Are We? Delving into the Rich History of Our Foundation
Tracing the Origins of the Foundation:
In 1997, a pioneering group of patients, caregivers, and families informally united to offer mutual support. By 2001, this collective became the officially named National Leiomyosarcoma Foundation, attaining its 501c3 status. Since 2002, the NLMSF has actively funded research. Today, we are proud to be distinguished as a 100% trusted organization by Charity Navigator, hold a Guide Star Gold designation, and are consistently recognized as a ‘Top Rated Charity’ by Great Nonprofits.”
Our Foundation's Board Members: A comprehensive showcase featuring photographs, names, and a designation as an LMS Survivor, Caregiver, or Friend of the Foundation, along with their respective locations across states or countries
Board Members
Achee, Annie - Colorado
Achee, Mitch - Colorado
Aguilar, Alex
Bain, Kathleen - Colorado
Forgess, Lynne - Philadelphia
Hancock, Chris - Washington
Lee, Greg - Canada
Sebaney, Jacque, - Texas
Stoddard, Marlana- Oregon
Williams, Chandalyn
Medical Advisory Committee
Janai Karr-Ascher, MD
Assistant Professor/Carr-Ascher Lab
UC Davis, Sacramento
Dr Nam Quoc Bui
Clinical Assistant Professor of Medicine at the Stanford Cancer Institute
Elizabeth Davis, MD
Assistant Professor of Medicine
Medical Director
Vanderbilt- Ingram Cancer Center
Nashville, TN
Mihaela Druta, MD
Moffitt Cancer Center and Research Institute
Tampa, FL
Kenneth Cardona, MD FACS
Emory Winship Cancer Institute
Atlanta, GA
Kristen Ganjoo
Sarcoma Specialist at Stanford Health Care
Suzanne George, MD
Associate Professor of Medicine, Harvard Medical School
Rebecca Gladdy, MD, PhD
Surgeon Scientist and Associate Professor at the University of Toronto
Matthew Hemming, MD, PhD
Medical Oncologist and Physician Scientist
Dana-Farber Cancer Institute, Massachusetts and Harvard Medical School
Evita Henderson-Jackson, MD
Pathologist Anatomic Pathology & Clinical Pathology Moffitt Cancer Center, Tampa, FL
NLMSF Community Ambassadors
